In clinical research, we often seek a "smoking gun"—a single molecule or gene that explains a disease. However, recent evidence suggests that chronic conditions like type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and dementia are better understood through the lens of composite indices and surrogate biomarkers. These tools do not just measure a single substance; they capture the interaction between multiple physiological systems.
While these markers offer powerful predictive capabilities, the field currently faces a "causality gap." Most findings rely on cross-sectional data—snapshots in time that show two things happening together without proving which one caused the other.
The Power of Composite Indices
Traditional markers like fasting glucose or LDL cholesterol provide a narrow view of health. Researchers are increasingly moving toward composite indices that integrate multiple data points to provide a more holistic "stress test" of a patient’s metabolism.
A prime example is the Triglyceride Glucose-Waist-to-Height Ratio (TyG-WtHR). As Hui Cai and colleagues demonstrated in Association between different insulin resistance surrogates and osteoarthritis, this index outperforms the traditional "gold standard" (HOMA-IR) for predicting osteoarthritis. Why? Because it combines a chemical marker of insulin resistance (triglycerides and glucose) with a physical marker of central obesity. This synergy captures the metabolic environment that drives joint degradation more effectively than blood chemistry alone.
Similarly, Jianjun Wang found that the TyG-WHtR index is a potent predictor of gallstone disease, identifying a non-linear relationship where risk accelerates once a certain metabolic threshold is crossed. Other successful ratios include:
- NHHR (Non-HDL to HDL ratio): Yuhao Yang showed this ratio is a low-cost, non-invasive tool for screening NAFLD, as it captures the balance between "pro-fatty" and "anti-fatty" lipid transport.
- SIRI (Systemic Inflammation Response Index): Jinhao Li used this to mediate the relationship between BMI and liver fibrosis, showing how systemic inflammation acts as the "bridge" between obesity and organ damage.
Non-Invasive Windows into Systemic Health
Beyond blood work, researchers are identifying structural surrogates—physical changes in the body that mirror internal pathology.
The eye has emerged as a primary "window." Junwei Wang and Ping Liu have shown that retinal vascular abnormalities like "arteriovenous nicking" are significant indicators of coronary heart disease and stroke history. Because the retina is the only place where we can non-invasively observe microvasculature, these changes serve as a proxy for the damage occurring in the vessels of the heart and brain.
Body composition is another critical surrogate. Li Li identified the Fat-to-Muscle Ratio (FMR) as a superior predictor of chronic kidney disease compared to BMI. This is intuitive: BMI cannot distinguish between a muscular athlete and an individual with sarcopenic obesity. FMR captures the specific risk of having too much metabolic "burden" (fat) and too little metabolic "engine" (muscle).
The Causality Gap
Despite the predictive power of these markers, nearly every major study in this area—from Kirsi Hannele Pietiläinen’s work on lipidomic profiles in twins to Xin Jiang’s research on physiological complexity in frailty—highlights a fundamental limitation: the cross-sectional design.
A cross-sectional study is like a single frame of a movie. If we see a car touching a wall in a photo, we know there is a crash, but we don't know if the car hit the wall or if the wall fell on the car. In metabolic research, this means we often cannot tell if:
- The biomarker (e.g., high serotonin or low Vitamin D) caused the disease.
- The disease caused the biomarker levels to change.
- A third, unmeasured factor (e.g., genetics or diet) caused both.
For example, Nina Wawro found that higher Vitamin D levels were associated with more eczema, a counter-intuitive finding that might be explained by "reverse causality"—perhaps parents of children with allergies give them more supplements.
The Path Forward: Longitudinal Integration
To bridge this gap, the research direction is shifting toward longitudinal tracking. By measuring these composite indices (like TyG or NHHR) and structural surrogates (like retinal thickness) repeatedly over years, researchers can establish a temporal sequence.
The goal is to move from association (knowing that A and B happen together) to prediction (knowing that a change in A today reliably forecasts B five years from now). As Feng Xu demonstrated with 1,5-anhydro-D-glucitol and nerve damage, identifying markers that capture "blind spots" in current testing—like short-term glucose spikes—is the first step toward a more proactive, preventative model of medicine.